BioSpace News Archive

Business

Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors

Ultragenyx Pharmaceutical Inc. today announced the appointment of Corsee Sanders, Ph.D., to the Board of Directors, effective June 29, 2021.

June 30, 2021
·
2 min read
Deals

electroCore Announces Pricing of $18.0 Million Public Offering of Common Stock

electroCore, Inc. today announced the pricing of an underwritten public offering of 18,000,000 shares of its common stock at a public offering price of $1.00 per share.

June 30, 2021
·
4 min read
Business

DELIC Labs Announces Partnership Agreement with Agilent Technologies

Delic Corp today announced that its subsidiary, DELIC Labs , has entered into a partnership agreement with Agilent, a global leader in life sciences, diagnostics, and applied chemical markets.

June 30, 2021
·
6 min read
FDA

Abbott’s XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients

Abbott (NYSE: ABT) today announced its XIENCE family of stents has received U.S. Food and Drug Administration (FDA) approval for one-month (as short as 28 days) DAPT labeling for high bleeding risk (HBR) patients

June 30, 2021
·
4 min read
ModivCare Inc. to Present at the CJS Securities 21st Annual New Ideas Summer Conference

ModivCare Inc. today announced that the Company is scheduled to present at the CJS Securities 21st Annual New Ideas Summer Conference, which will be held virtually, on Tuesday, July 13, 2021 at 2:20pm Eastern Time.

June 30, 2021
·
1 min read
Giiant Pharma inc Extended Its Seed Round With AQC Capital and CQDM to Ensure Reaching Clinical Proof-of-Concept

Giiant Pharma inc. announced that is closed an additional financing of $750,000 from AQC Capital and $500,000 from CQDM for a total of $1.25 million.

June 30, 2021
·
2 min read
Business

Osmotica Subsidiary RVL Pharmaceuticals, Focused on Eye Care and Ocular Aesthetics, Strengthens and Expands Leadership Team

Osmotica Pharmaceuticals plc today announced that J. Aaron Green will join the leadership team of RVL Pharmaceuticals, Inc.

June 30, 2021
·
5 min read
Business

CureVac Announces Appointment of Dr. Malte Greune as Chief Operating Officer and Transition of Dr. Florian von der Mülbe to Lead Accelerated Development of The RNA Printer(R)

CureVac N.V. today announced the appointment of Dr. Malte Greune as Chief Operating Officer (COO) effective July 1, 2021.

June 30, 2021
·
7 min read
Pharm Country

SIGA Supplies TPOXX® (Tecovirimat) as Compassionate Treatment for Monkeypox Case in the United Kingdom

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it provided TPOXX® (tecovirimat) to Liverpool University Hospitals NHS Foundation Trust, in the United Kingdom (UK

June 30, 2021
·
5 min read
Drug Development

Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-ANG3 for Treatment of Mixed Dyslipidemia

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patient in AROANG3-2001, a Phase 2b clinical study of ARO-ANG3, the company’s investigational RNA interference (RNAi) therapeutic being developed as a treatment for patients with mixed dyslipidemia.

June 30, 2021
·
4 min read